All
All

What are you looking for?

All
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

New generation of preparations for amplifications of DNA fragments by polymerase chain reaction

Project goals

Amplification of DNA fragments by polymerase chain reaction (PCR) is extensively used in basic research as well as for diagnostic and commercial purposes. With increasing numbers of applications of PCRs, the need for stabile formulations of complex PCR mixtures is growing. Our preliminary experiments indicated that lyophilization of complex PCR mixtures (containing DNA polymerases, nucleotides, buffer, anti-polymerase monoclonal antibodies and additives) decreased performance of PCR. To further simplifyPCR set up and to overcome problems with lyophilization we will test the stabilizing effect of additives on rehydratation and dehydratation of complex PCR mixtures. The additives will include sugars, polyethylenglycol, Ficol and others. Furthermore, wewill search for more advantageous properties of mutagenized Taq DNA polymerase. This research could provide a theoretical background for production of a new generation of preparations for amplification of DNA fragments by PCR.

Keywords

polymerase chain reactionTaq DNA polymeraselyophilizationmutagenesis

Public support

  • Provider

    Academy of Sciences of the Czech Republic

  • Programme

    The supprot of targeted research projects (National proramme of research)

  • Call for proposals

    Podpora projektů cíleného výzkumu 1 (SAV02005-CI)

  • Main participants

  • Contest type

    VS - Public tender

  • Contract ID

    1QS500520551

Alternative language

  • Project name in Czech

    Nová generace přípravků pro amplifikaci DNA fragmentů pomocí polymerázové řetězcové reakce

  • Annotation in Czech

    Amplifikace DNA fragmentů polymerázovou řetězcovou reakcí (PCR) je extenzivně využívaná jak v základním výzkumu tak v diagnostice a pro komerční účely. S narůstajícím počtem aplikací PCR se zvyšují požadavky na formulaci stabilních přípravků pro PCR. Naše předběžné výsledky ukázaly, že lyofilizace kompletních reakčních směsí pro PCR (obsahujících DNA polymerázy, nukleotidy, pufr, anti-polymerázové monoklonální protilátky a aditiva) snižuje účinnost PCR. Abychom dále zjednodušili přípravu rekčních směsípro PCR a řešili problémy s lyofilizací budeme testovat stabilizační efekt aditiv na dehydrataci a rehydrataci komplexních směsí pro PCR. Aditiva budou zahrnovat cukry, polyethylenglykol, Ficol a další. Dále budeme hledat nové výhodnější formy mutagenizované Taq DNA polymerázy. Tento výzkum bude představovat teoretickou bazi pro produkci nové generace přípravků pro amplifikaci DNA fragmentů v PCR.

Scientific branches

  • R&D category

    NV - Nonindustrial research (Applied research excluded Industrial research)

  • CEP classification - main branch

    EB - Genetics and molecular biology

  • CEP - secondary branch

    EI - Biotechnology and bionics

  • CEP - another secondary branch

    CE - Biochemistry

  • 10603 - Genetics and heredity (medical genetics to be 3)
    10604 - Reproductive biology (medical aspects to be 3)
    10605 - Developmental biology
    10608 - Biochemistry and molecular biology
    10609 - Biochemical research methods
    20801 - Environmental biotechnology
    20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management
    20803 - Environmental biotechnology related ethics
    20901 - Industrial biotechnology
    20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation
    20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials
    30101 - Human genetics
    30401 - Health-related biotechnology
    30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)
    30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])
    30404 - Biomaterials (as related to medical implants, devices, sensors)
    30405 - Medical biotechnology related ethics
    40401 - Agricultural biotechnology and food biotechnology
    40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming
    40403 - Agricultural biotechnology related ethics

Completed project evaluation

  • Provider evaluation

    U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

  • Project results evaluation

    This project led to formulation of new reaction mixes for quantitative polymerase chain reaction (qPCR). These reaction mixes possess all constant components of qPCR and allow amplification even of long genomic DNA fragments.

Solution timeline

  • Realization period - beginning

    Jul 1, 2005

  • Realization period - end

    Dec 31, 2009

  • Project status

    U - Finished project

  • Latest support payment

    Mar 11, 2009

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP10-AV0-1Q-U/01:1

  • Data delivery date

    Apr 15, 2010

Finance

  • Total approved costs

    4,077 thou. CZK

  • Public financial support

    3,735 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    342 thou. CZK

Recognised costs

4 077 CZK thou.

Public support

3 735 CZK thou.

0%


Provider

Academy of Sciences of the Czech Republic

CEP

EB - Genetics and molecular biology

Solution period

01. 07. 2005 - 31. 12. 2009